US President Joe Biden has supported a proposal put forth to US Congress seeking permission to allow the US government to negotiate lower medicine prices for age-old people. But, the bill hit a hurdle in the US Congress as the bill failed to advance in a House of Representatives committee vote. Though many Democrats in Congress are in support of the bill, few members from the House energy and commerce committee voted in opposition to the bill.
However, the failure of Biden backed proposal is a victory for many pharmaceutical firms. The pharma companies have opposed allowing Medicare insurers to negotiate lower prices for medicine. Medicare is a healthcare program for elderly Americans formed by the US government.
The pharma firms aim to rebuild their public reputations making life-saving vaccines accessible to the patients. Reports say such moves are creating headaches to the Biden Administration and all together with the White House. But, the move on blocking the bill by the senate democrats reflects the power and influence of the senates on shaping legislation.